Literature DB >> 12144970

West Nile virus in New York City.

Wilfredo Lopez1.   

Abstract

In 1999, a cluster of encephalitis cases was detected in New York City. The city applied larvicide to standing water and aerially sprayed pesticides to control adult mosquitoes. The causative agent was West Nile virus, a type of encephalitis that had never before been transmitted in the western hemisphere. This experience offers many lessons for the practitioners of public health and of public health law. A public health infrastructure that does not lose sight of the old threats must be maintained. The public health and environmental governmental establishments must work together. Law is closely intertwined with policy and programmatic initiatives and can facilitate a better public health outcome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144970      PMCID: PMC3222283          DOI: 10.2105/ajph.92.8.1218

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  2 in total

1.  The outbreak of West Nile virus infection in the New York City area in 1999.

Authors:  D Nash; F Mostashari; A Fine; J Miller; D O'Leary; K Murray; A Huang; A Rosenberg; A Greenberg; M Sherman; S Wong; M Layton
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

2.  West Nile virus activity--New York and New Jersey, 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-07-21       Impact factor: 17.586

  2 in total
  3 in total

1.  Relating West Nile virus case fatality rates to demographic and surveillance variables.

Authors:  Julie Tackett; Richard Charnigo; Glyn Caldwell
Journal:  Public Health Rep       Date:  2006 Nov-Dec       Impact factor: 2.792

Review 2.  Effective surveillance systems for vector-borne diseases in urban settings and translation of the data into action: a scoping review.

Authors:  Florence Fournet; Frédéric Jourdain; Emmanuel Bonnet; Stéphanie Degroote; Valéry Ridde
Journal:  Infect Dis Poverty       Date:  2018-09-03       Impact factor: 4.520

3.  A strategic vaccine facility for the UK.

Authors:  Jacqueline M Duggan; Timothy J G Brooks
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.